The novel anticoagulants: The surgeons' prospective

    loading  Checking for direct PDF access through Ovid

Abstract

Anticoagulants can complicate the approach to the management of patients undergoing operative interventions. We review new anticoagulants that have been introduced recently to the market or that are undergoing investigations for treatment of nonvalvular atrial fibrillation and venous thromboembolism prophylaxis: Dabigatran, rivaroxaban, apixiban, and edoxaban.

Related Topics

    loading  Loading Related Articles